Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Columnists


About James O'Rourke

James O'Rourke
James O'Rourke, Clarity Analytics
James is a freelance information services professional for various media relation firms and consultant to several publicly traded entities. He ...


James O'Rourke's Most Recent Articles

Typhoon Highly Prospective for New Gold Discovery, Drilling the Prolific Porcupine-Destor Break

Typhoon Exploration Inc. (TSX-V: TYP) (US Listing: TYPFF) (Berlin: TPH1)is the subject of a...

James O'Rourke | October 2, 2020

$14K invested in gold explorer Great Bear 3 turned into $1M, put Straightup Resources on your...

Astute investors have started to pour money into precious metal related investments. We urge you...

James O'Rourke | September 15, 2020

Will Straightup Resources Inc. become the next Great Bear Resources?

Straightup Resources Inc. (CSE: ST) is a new public company focused on advancing its flagship RLX...

James O'Rourke | June 30, 2020

NioBay Advancing Toward Goal of 4th Nb Producer in the World

NioBay Metals Inc. (TSX-V: NBY) (US Listing: MDNNF) is focused on advancing its flagship 100...

James O'Rourke | June 5, 2020

dynaCERT on Haywood Securities’ radar, ESG benefactor ready to scale

dynaCERT Inc. (TSX-V: DYA) (OTCQB: DYFSF) (Frankfurt: DMJ) is the subject of coverage by analysts...

James O'Rourke | June 3, 2020

Valeo Pharma bringing to market drug undergoing clinical trials to improve survival of COVID-19

Valeo Pharma Inc. (CSE: VPH) is a fast-growing revenue generating specialty pharmaceutical...

James O'Rourke | May 22, 2020

DIAGNOS poised for parabolic move as first of new cardio AI Applications comes to market

DIAGNOS Inc. (TSX-V: ADK) (OTCQB: DGNOF) (Frankfurt: 4D4) is a Canadian-based healthcare software...

James O'Rourke | May 5, 2020

dynaCERT Invited to Speak at World Climate Summit on Future of World Carbon Credits, ...

dynaCERT Invited to Speak at World Climate Summit on Future of World Carbon Credits, Sales...

James O'Rourke | February 28, 2020

dynaCERT attracting major strategic investors entering 2020, exponential growth potential

Order of Canada member Eric Sprott, plus Dr. Jorg Mosolf (of Europe’s MOSOLF Group) are two of...

James O'Rourke | December 31, 2019

MacDonald Mines building a significant Gold asset near Sudbury

James O'Rourke | November 13, 2019
1 2 3 4 Next